ARPA-H Mission Office ISOs
Supports United States mission teams with boundary-pushing health initiatives beyond existing programme limits.
ARPA-H's Mission Office Innovative Solution Openings (ISOs) form the agency's rolling Open Broad Agency Announcement, comprising four parallel solicitations — one per Mission Office — each with its own solicitation number (ARPA-H-SOL-24-103 through 24-106). The four Mission Offices are Health Science Futures, Proactive Health, Resilient Systems, and Scalable Solutions, each covering a distinct str…
Health R&D in one of four Mission Office focus areas: Health Science Futures (removing scientific limits to the future of care), Proactive Health (prevention before patienthood), Resilient Systems (robust integrated health systems), or Scalable Solutions (geography, distribution, manufacturing, data, and equity).
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Start hereTRL Levels Explained for Deeptech Founders
Learn what TRL levels mean, how to estimate technology readiness, and how TRL affects grants, EIC Accelerator, SBIR/STTR, funding stage, and application evidence.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
More from ARPA-H
All grants from this funder →ARPA-H SBIR/STTR
🇺🇸ARPA-H · United States
Funds United States small businesses bridging health and neuroscience technologies from feasibility into advanced development.
ARPA-H Program ISOs (topic-specific)
🇺🇸ARPA-H · United States
Funds United States health initiatives through topic-focused pathways across multiple mission areas and agencies.
ARPA-H Initiatives & Sprints
🇺🇸ARPA-H · United States
Runs fast-turnaround health technology opportunities in United States for high-potential exploratory science and engineering.
BioStabilization Systems (BoSS)
🇺🇸ARPA-H · United States
Funds teams engineering room-temperature storage for biologic drugs and cell therapies.
Intelligent Generator of Research (IGoR)
🇺🇸ARPA-H · United States
Funds teams building an AI-orchestrated ecosystem to speed up biomedical research.
One Comprehensive Universal Radiotherapy for Everyone (1-CURE)
🇺🇸ARPA-H · United States
Funds research teams developing a single low-cost radiotherapy treatment for all cancers.
Similar grants
Browse the directory →
NIH Common Fund Venture Program — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports high-potential short- to medium-range initiatives that can seed major breakthroughs.
DARPA BTO Office-wide BAA
🇺🇸DARPA · United States
Funds United States convergence work in biology, neurotechnology, and synthetic biology for strategic defense purposes.
ASPIRE Reduction-to-Practice (Seed)
🇺🇸NCATS · United States
Supports translational chemistry and automation platform development through university-linked partnerships.
Assay Validation of High Quality Markers for Clinical Studies in Cancer
🇺🇸NIH · United States
Funds two years of analytical validation then three of clinical validation for a cancer biomarker assay that already works on human samples.
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders
🇺🇸NIH · United States
Funds the first human trials of a novel-mechanism psychiatric drug or a novel neuromodulatory device, with milestones gating each step.
Complement-ARIE — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports development of human-based new approach methodologies replacing animal models in relevant research.